Proteon Pharmaceuticals SA is an innovative biotech company using bacteriophages as the foundation for preventing and eradicating bacterial diseases in food animals, humans and plants. Bacteriophages are naturally existing organisms occurring in the microbiome.
Due to the large-scale application of antibiotics – over two-thirds of which are used in the production of animal protein – bacteria are growing resistant. Conservatively, at least 2 million Americans are already infected with antibiotic-resistant infections every year, and at least 23,000 die as a direct result, according to the Centers for Disease Control and Prevention. This makes antibiotic resistance one of the biggest threats to global health, food security, and development today, as per the World Health Organization.
Phages are naturally occurring organisms that target one type of bacteria. In comparison, antibiotics attack both the harmful bacteria and the resident friendly bacteria, leading to opportunistic infection and resistance.
Proteon has two main products on the market: a solution against pseudomonas and aeromonas infections in fish and a solution against salmonella infections in poultry. The company also has custom vaccines and farm-monitoring services that are market ready, and an impressive pipeline of product development.